Caldera Medical and IVUmed today announced their partnership to eradicate the incapacitation and suffering of women with Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP).
Caldera Medical, a medical device company, develops differentiated surgical implants for the treatment of SUI and POP.
"Millions of women in poverty-stricken countries are incapacitated by incontinence and/or prolapse and are not receiving the care they need," stated Bryon L. Merade, Chairman and CEO, Caldera Medical, adding, "teaming up with IVUmed to eliminate the suffering of women with SUI and POP will enable us to fulfill our mission of improving the quality of life for women."
"Caldera Medical is a great partner and this partnership reflects our desire to collaborate with companies that share our vision of making quality urological care available to people worldwide. This partnership underscores our commitment to Teach One, Reach Many and the impact that each of our volunteers and donors has on the world," said Dr. Kurt McCammon, Chief Medical Officer, IVUMed.
IVUmed will coordinate humanitarian trip logistics and workshops to train local surgeons with support from Societe Internationale d’Urologie (SIU). Caldera Medical will sponsor skilled American surgeons to provide the best available treatment to underprivileged women. In addition, Caldera Medical will donate surgical implants and provide reusable introducers during humanitarian trips. The partnership has been formed to work together in alleviating one million women suffering from SUI and POP by 2025.
Caldera Medical recently launched Women’s Health Initiative to partner with leading surgeons to advance education and provide humanitarian aid while delivering care to impoverished women suffering from SUI and POP regardless of their ability to pay. The initiative specifically involves dispatching teams of surgeons to underprivileged areas to treat patients and to provide proper training to local physicians.
Caldera Medical’s product lines include Desara® Sling System for the treatment of SUI and Vertessa® Lite for use in abdominal sacrocolpopexy procedures for the treatment of POP.